BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9480172)

  • 1. [Pharmacologic treatment for ventricular arrhythmias].
    Halawa B
    Pol Merkur Lekarski; 1997 Aug; 3(14):45-9. PubMed ID: 9480172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiarrhythmic agents in the prevention of sudden cardiac death].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current approaches to evaluation and management of patients with ventricular arrhythmias.
    Buxton AE; Kirk MM; Michaud GF
    Med Health R I; 2001 Feb; 84(2):58-62. PubMed ID: 11272662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular arrhythmias: medical therapy, device treatment, and indications for electrophysiologic study.
    Sager PT; Batsford WP
    Cardiol Clin; 1988 Feb; 6(1):37-47. PubMed ID: 3048673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arrhythmia risk stratification based on etiological and anatomo-structural factors].
    Disertori M; Dallafior D; Marini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1265-9. PubMed ID: 11838346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; MunicinĂ² A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiac insufficiency: prevention of ventricular arrhythmias].
    Mabo P; Leclercq C; Pavin D
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():23-8. PubMed ID: 10830085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiarrhythmia agents in heart failure].
    Duc P
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4 Suppl):595-8. PubMed ID: 7487307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive factors of induction of ventricular arrhythmia under amiodarone].
    Bourret N; Kirkorian G; Chevalier P; Bellon C; Richalet C; Bouchayer D; Bonnefoy E; Touboul P
    Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1277-81. PubMed ID: 8952825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular arrhythmias.
    Kavanagh KM; Wyse DG
    CMAJ; 1988 May; 138(10):903-13. PubMed ID: 3284626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular arrhythmias during left ventricular assist device support.
    Bedi M; Kormos R; Winowich S; McNamara DM; Mathier MA; Murali S
    Am J Cardiol; 2007 Apr; 99(8):1151-3. PubMed ID: 17437746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic therapy in patients with ventricular tachyarrhythmias.
    Wyse DG
    Cardiol Clin; 1993 Feb; 11(1):65-83. PubMed ID: 8435825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias.
    Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.